3,4-DI-SUBSTITUTED MALEIMIDE COMPOUNDS AS CXC-CHEMOKINE RECEPTOR ANTAGONISTS,申请号WO2002US32628-传众专利搜索

发明名称	3,4-DI-SUBSTITUTED MALEIMIDE COMPOUNDS AS CXC-CHEMOKINE RECEPTOR ANTAGONISTS
摘要	Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
申请公布号	WO03031440(A1)	申请公布日期	2003.04.17
申请号	WO2002US32628	申请日期	2002.10.11
申请人	SCHERING CORPORATION;PHARMACOPEIA, INC.	发明人	TAVERAS, ARTHUR, G.;DWYER, MICHAEL;FERREIRA, JOHAN, A.;GIRIJAVALLABHAN, VIYYOOR, M.;CHAO, JIANPING;BALDWIN, JOHN, J.;MERRITT, J., ROBERT;LI, GE
分类号	A61K31/337;A61K31/4015;A61K31/402;A61K31/4025;A61K31/4155;A61K31/4192;A61K31/4439;A61K31/454;A61K31/496;A61K31/506;A61K31/5377;A61K31/56;A61K38/00;A61K38/21;A61K38/22;A61K38/55;A61K39/395;A61K45/00;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P7/02;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P11/10;A61P13/12;A61P17/02;A61P17/06;A61P19/02;A61P19/06;A61P19/10;A61P21/00;A61P25/00;A61P25/28;A61P27/02;A61P31/04;A61P31/18;A61P31/20;A61P31/22;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D207/44;C07D207/456;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D409/14;C07D417/12;(IPC1-7):C07D409/12;C07D401/08;A61K31/401	主分类号	A61K31/337
代理机构		代理人
主权项
地址